Publications by authors named "Max Shenin"

Claim this Profile
A
A prospective, open-label, non-comparative study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis.
Annemarie Schorpion, Max Shenin, Robin Neubauer, Chris T Derk

BMC Rheumatol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases.
Steffan W Schulz, Max Shenin, Amy Mehta, Amal Kebede, Marshall Fluerant

Rheumatol Int· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary amyloidosis causing diffuse alveolar hemorrhage.
Max Shenin, Wen Xiong, Manisha Naik, Nora Sandorfi

J Clin Rheumatol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors.
Kristin M Ingraham, Marie S O'Brien, Max Shenin, Chris T Derk, Virginia D Steen

J Rheumatol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis.
Chris T Derk, Elizabeth Grace, Max Shenin, Manisha Naik, Steffan Schulz

Rheumatology (Oxford)· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of mycophenolate mofetil for the treatment of systemic sclerosis.
Max Shenin, Manisha Naik, Chris T Derk

Endocr Metab Immune Disord Drug Targets· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis